PepperLime Health Acquisition Corp: Nasdaq/NYSE listing notice — PepperLime Health SPAC to delist March 21; ceases operations, trust disbursement March 22

PepperLime Health Acquisition Corp

Nasdaq notice for audit committee non-compliance after Michelle Fang's board resignation in Jan 2024.
Company decided to cease all operations except winding up; last trading day March 21, 2024.
Public shareholders to receive trust disbursements on or about March 22, 2024.
Company has no plan to regain compliance with Nasdaq Listing Rule 5605.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

PepperLime Health Acquisition Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605

Exact text from the filing

March 11, 2024, PepperLime Health Acquisition Corporation (the “Company”) received a notice (the “Nasdaq Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that as a result of Ms. Michelle Fang’s resignation from the Company’s board of directors in January 2024, the Company no longer complies with Nasdaq’s audit committee requirement as set forth in Nasdaq Listing Rule 5605, including the requirement that there are at least three independent directors on the Company’s audit committee. The Company is provided a cure period until the earlier of the Company’s next annual shareholders’

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-24-034235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.